Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


6 AIDS Res Hum Retroviruses
1 Ann Intern Med
3 Antimicrob Agents Chemother
2 Clin Infect Dis
15 J Acquir Immune Defic Syndr
1 J Clin Invest
1 J Med Virol
3 J Virol
1 Lancet Respir Med
1 MMWR Morb Mortal Wkly Rep
3 Neurology
1 Pediatr Infect Dis J
9 PLoS One
3 PLoS Pathog
1 Vaccine


  1. GOURLAY AJ, Pharris AM, Noori T, Supervie V, et al
    Towards standardized definitions for monitoring the continuum of HIV care in Europe.
    AIDS. 2017;31:2053-2058.
    >> Share

  2. ZOBOLI F, Ripamonti D, Benatti SV, Comi L, et al
    Autoimmune hepatitis and HIV infection: two case reports and review of the literature.
    AIDS. 2017;31:2172-2175.
    >> Share

  3. HYLE EP, Jani IV, Rosettie KL, Wood R, et al
    The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.
    AIDS. 2017;31:2135-2145.
    >> Share

  4. LAKE AC
    Hepatitis B reactivation in a long-term nonprogressor due to nivolumab therapy.
    AIDS. 2017;31:2115-2118.
    >> Share

  5. GIANELLA S, Chaillon A, Mutlu EA, Engen PA, et al
    Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.
    AIDS. 2017;31:2059-2067.
    >> Share

    AIDS Res Hum Retroviruses

  6. FLEURY HJ, Tumiotto C, Bellecave P, Recordon-Pinson P, et al
    Therapeutic vaccine against HIV, viral variability, CTL epitopes and genetics of patients.
    AIDS Res Hum Retroviruses. 2017.
    >> Share

  7. WILLIAMS B, Ghosh M, Boucher CAB, Bushman F, et al
    A summary of the second annual HIV Microbiome workshop.
    AIDS Res Hum Retroviruses. 2017.
    >> Share

  8. MUJUGIRA A, Baeten J, Kidoguchi L, Haberer J, et al
    High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy.
    AIDS Res Hum Retroviruses. 2017.
    >> Share

  9. ZHANG A, Pan X, Wu F, Zhao Y, et al
    'What Would an HIV Cure Mean to You?': Qualitative Analysis from a Crowdsourcing Contest in Guangzhou, China.
    AIDS Res Hum Retroviruses. 2017 Sep 11. doi: 10.1089/AID.2017.0188.
    >> Share

  10. TACHIBANA S, Sasaki M, Tanaka T, Inoue M, et al
    A 2-4-amino-acid deletion in the V5 region of HIV-1 Env gp120 confers viral resistance to the broadly neutralizing human monoclonal antibody, VRC01.
    AIDS Res Hum Retroviruses. 2017.
    >> Share

  11. CHIMUKANGARA B, Manasa J, Mitchell R, Nyabadza G, et al
    Community Based Antiretroviral Treatment in Rural Zimbabwe.
    AIDS Res Hum Retroviruses. 2017.
    >> Share

    Ann Intern Med

  12. KATTAKUZHY S, Gross C, Emmanuel B, Teferi G, et al
    Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.
    Ann Intern Med. 2017 Aug 8. doi: 10.7326/M17-0118.
    >> Share

    Antimicrob Agents Chemother

  13. PATEL S, Leibrand CR, Palasuberniam P, Couraud PO, et al
    Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01307.
    >> Share

  14. ZHAO N, Wang G, Das AT, Berkhout B, et al
    Combinatorial CRISPR-Cas9 and RNAi attack on HIV-1 DNA and RNA can lead to cross-resistance.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01486.
    >> Share

  15. KOSAKA M, Ushiki A, Ikuyama Y, Hirai K, et al
    Efficacy and toxicity of low-dose trimethoprim-sulfamethoxazole for the treatment of pneumocystis pneumonia in patients without human immunodeficiency virus infection: A four-center retrospective study.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01173.
    >> Share


  16. SIEMIENIUK RAC, Lytvyn L, Mah Ming J, Mullen RM, et al
    Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline.
    BMJ. 2017;358:j3961.
    >> Share

    Clin Infect Dis

  17. MACIAS J, Mancebo M, Merino D, Tellez F, et al
    Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
    Clin Infect Dis. 2017;65:1012-1019.
    >> Share

  18. TRICKEY A, May MT, Schommers P, Tate J, et al
    CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Clin Infect Dis. 2017;65:959-966.
    >> Share

    J Acquir Immune Defic Syndr

  19. FABBIANI M, Muscatello A, Perseghin P, Bani M, et al
    Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated With the Evolution of Cognitive Performance in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2017;76:219-224.
    >> Share

  20. SMOLDERS EJ, Smit C, T M M de Kanter C, Dofferiiof ASM, et al
    Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients.
    J Acquir Immune Defic Syndr. 2017;76:193-199.
    >> Share

  21. MISRA K, Udeagu CC
    Disparities in Awareness of HIV Postexposure and Preexposure Prophylaxis Among Notified Partners of HIV-Positive Individuals, New York City 2015-2017.
    J Acquir Immune Defic Syndr. 2017;76:132-140.
    >> Share

  22. LANDOVITZ RJ, Beymer M, Kofron R, Amico KR, et al
    Plasma Tenofovir-levels to Support Adherence to TDF/FTC Pre-exposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001538.
    >> Share

  23. FIRNHABER C, Swarts A, Goeieman B, Rakhombe N, et al
    Cryotherapy reduces progression of cervical intraepithelial neoplasia grade 1 in South African HIV-infected women: a randomized, controlled trial.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001539.
    >> Share

  24. VALVERDE EE, Oster AM, Xu S, Wertheim JO, et al
    HIV Transmission Dynamics among Foreign-born Persons in the United States.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001541.
    >> Share

  25. PLOTZKER R, Seekaew P, Jantarapakde J, Pengnonyang S, et al
    The Importance of Risk Perception: Predictors of PrEP Acceptance Among Thai MSM and TG Women at a Community-Based Health Service.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001536.
    >> Share

  26. ONDIEK J, Namukaya Z, Mtapuri-Zinyowera S, Balkan S, et al
    Multicountry Validation of SAMBA - A Novel Molecular Point-of-Care Test for HIV-1 Detection in Resource-Limited Setting.
    J Acquir Immune Defic Syndr. 2017;76:e52-e57.
    >> Share

  27. STONER MCD, Edwards JK, Miller WC, Aiello AE, et al
    The effect of schooling on age-disparate relationships and number of sexual partners among young women in rural South Africa enrolled in HPTN 068.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001544.
    >> Share

  28. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery: Erratum.
    J Acquir Immune Defic Syndr. 2017;76:e64.
    >> Share

  29. WILTON J, Mishra S, Tan DHS
    Considerations for Using the HIRI-MSM Screening Tool to Identify MSM Who Would Benefit Most From PrEP.
    J Acquir Immune Defic Syndr. 2017;76:e58-e61.
    >> Share

  30. SANDFORT TGM, Knox JR, Alcala C, El-Bassel N, et al
    Substance Use and HIV Risk Among Men Who Have Sex With Men in Africa: A Systematic Review.
    J Acquir Immune Defic Syndr. 2017;76:e34-e46.
    >> Share

  31. FERRETTI F, Mora-Peris B, Underwood J, Waldman A, et al
    Cognitive Impairment in a Clinical Setting.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001547.
    >> Share

  32. ECKARD AR, O'Riordan MA, Rosebush JC, Ruff JH, et al
    Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-infected Youth.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001545.
    >> Share

  33. ZHANG HL, Rhea SK, Hurt CB, Mobley VL, et al
    HIV pre-exposure prophylaxis implementation at local health departments: a statewide assessment of activities and barriers.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001546.
    >> Share

    J Clin Invest

  34. VAN ZYL GU, Katusiime MG, Wiegand A, McManus WR, et al
    No evidence of HIV replication in children on antiretroviral therapy.
    J Clin Invest. 2017 Sep 11. pii: 94582. doi: 10.1172/JCI94582.
    >> Share

    J Med Virol

  35. UCCIFERRI C, Tamburro M, Falasca K, Sammarco ML, et al
    Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men.
    J Med Virol. 2017 Sep 14. doi: 10.1002/jmv.24943.
    >> Share

    J Virol

  36. BOMSEL M, Ganor Y
    Calcitonin gene-related peptide induces HIV-1 proteasomal degradation in mucosal Langerhans cells.
    J Virol. 2017 Sep 13. pii: JVI.01205-17. doi: 10.1128/JVI.01205.
    >> Share

  37. TEIGLER JE, Zelinskyy G, Eller MA, Bolton DL, et al
    Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
    J Virol. 2017 Sep 13. pii: JVI.01263-17. doi: 10.1128/JVI.01263.
    >> Share

  38. LITTWITZ-SALOMON E, Schimmer S, Dittmer U
    The dose of retroviral infection determines the induction of anti-viral NK cell responses.
    J Virol. 2017 Sep 13. pii: JVI.01122-17. doi: 10.1128/JVI.01122.
    >> Share

    Lancet Respir Med

  39. LESSEM E, Cox V, Furin J
    Bedaquiline or delamanid for rifampin-resistant tuberculosis?
    Lancet Respir Med. 2017 Sep 5. pii: S2213-2600(17)30309.
    >> Share

    MMWR Morb Mortal Wkly Rep

    Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis.
    MMWR Morb Mortal Wkly Rep. 2017;66:959-960.
    >> Share


  41. Motor neuron disease in patients with HIV infection.
    Neurology. 2017;89:1200.
    >> Share

  42. RUBIN LH, Maki PM, Springer G, Benning L, et al
    Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression.
    Neurology. 2017 Sep 13. pii: 10.1212/WNL.0000000000004491.
    >> Share

  43. CYSIQUE LA, Becker JT
    HIV-related cognitive decline despite viral suppression and complex confounds in American women.
    Neurology. 2017 Sep 13. pii: 10.1212/WNL.0000000000004503.
    >> Share

    Pediatr Infect Dis J

  44. SULIS G, Amadasi S, Odone A, Penazzato M, et al
    Antiretroviral Therapy in HIV Infected Children with Tuberculosis: A Systematic Review.
    Pediatr Infect Dis J. 2017 Sep 7. doi: 10.1097/INF.0000000000001784.
    >> Share

    PLoS One

  45. KEATING SM, Dodge JL, Norris PJ, Heitman J, et al
    The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
    PLoS One. 2017;12:e0181004.
    >> Share

  46. LIM SH, Mburu G, Bourne A, Pang J, et al
    Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: Findings from an online survey.
    PLoS One. 2017;12:e0182838.
    >> Share

  47. NAIDOO K, Hassan-Moosa R, Yende-Zuma N, Govender D, et al
    High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa.
    PLoS One. 2017;12:e0184124.
    >> Share

  48. SHIMADA T, Nagata N, Okahara K, Joya A, et al
    PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection.
    PLoS One. 2017;12:e0184699.
    >> Share

  49. GUPTE AN, Wong ML, Msandiwa R, Barnes GL, et al
    Factors associated with pulmonary impairment in HIV-infected South African adults.
    PLoS One. 2017;12:e0184530.
    >> Share

  50. BLANCO-GUILLOT F, Delgado-Sanchez G, Mongua-Rodriguez N, Cruz-Hervert P, et al
    Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0184675.
    >> Share

  51. SOKUNBI OJ, Ekure EN, Temiye EO, Anyanwu R, et al
    Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria.
    PLoS One. 2017;12:e0184287.
    >> Share

  52. HOREMHEB-RUBIO G, Ramos-Cervantes P, Arroyo-Figueroa H, Avila-Rios S, et al
    High HPgV replication is associated with improved surrogate markers of HIV progression.
    PLoS One. 2017;12:e0184494.
    >> Share

  53. ROLLO F, Latini A, Pichi B, Colafigli M, et al
    Prevalence and determinants of oral infection by Human Papillomavirus in HIV-infected and uninfected men who have sex with men.
    PLoS One. 2017;12:e0184623.
    >> Share

    PLoS Pathog

  54. KIJAK GH, Sanders-Buell E, Chenine AL, Eller MA, et al
    Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.
    PLoS Pathog. 2017;13:e1006620.
    >> Share

  55. Correction: CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.
    PLoS Pathog. 2017;13:e1006617.
    >> Share

  56. DUBROVSKAYA V, Guenaga J, de Val N, Wilson R, et al
    Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response.
    PLoS Pathog. 2017;13:e1006614.
    >> Share


  57. SUNDARAMURTHI JC, Ashokkumar M, Swaminathan S, Hanna LE, et al
    HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIV.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31168.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016